Comparable stake leader
First Light Asset Management, LLC
SEC ownership of Health Catalyst, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001636422.
Disclosed value leader
Mathew Paul Arens
Comparable rows
50/50
Latest evidence
14 Sep 2026
- Public ticker
- HCAT on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
First Light Asset Management, LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
First Light Asset Management, LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
14 Sep 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001636422
- Issuer location
- South Jordan, UT
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Health Catalyst, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
First Light Asset Managem...
Disclosed value leader
Mathew Paul Arens
Comparable rows
50/50
Latest evidence
14 Sep 2026
13D/G
13F
3/4/5
Lead comparable stake: 18%
13D/G row: First Light Asset Management, LLC
Showing 1-8 of 50 holder rows.
Quick read
First Light Asset Management, LLC leads the comparable SEC ownership view at 18%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens First Light Asset Management, LLC's linked filing trail.
Comparable ownership
Top 5
First Light Asset Management, LLC
18%
Stoney Lonesome HF LP
9.6%
Palogic Value Management, L.P.
7.1%
Impax Asset Management Group plc
5.4%
Whetstone Capital Advisors, LLC
4.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| First Light Asset Management, LLC |
13D/G
13F
Mathew P. Arens · Company
|
18%
|
$26,796,092
13,465,373 shares
|
-$909,928 | 12 Mar 2026 |
| Stoney Lonesome HF LP |
13D/G
COGHILL CLINT D
|
9.6%
|
$16,106,780
7,095,498 shares
|
+$1,786,837 | 30 Jun 2026 |
| Palogic Value Management, L.P. |
13D/G
13F
Palogic Value Management, LP · Company
|
7.1%
|
$11,179,894
5,374,949 shares
|
+$948,653 | 04 Sep 2026 |
| Impax Asset Management Group plc |
13D/G
13F
Company
|
5.4%
|
$7,960,000
4,000,000 shares
|
$0 | 30 Jun 2026 |
| Whetstone Capital Advisors, LLC |
13D/G
13F
Company
|
4.5%
|
$4,402,825
3,285,690 shares
|
-$3,346,316 | 04 Jun 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
1.5%
from 13D/G
|
$3,654,383
1,836,373 shares
|
— | 30 Jun 2026 |
| Mathew Paul Arens |
3/4/5
Director, 10%+ Owner
|
14%
|
$32,429,283
10,955,839 shares
|
— | 01 Dec 2025 |
| Simeon Kohl |
3/4/5
Chief Executive Officer, Director
|
3.8%
|
$5,104,645
2,856,385 shares
|
+$105,439 | 14 Sep 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$95,238.
Buys
$105,439
Insiders: 1
Sells
$200,677
Insiders: 2
Net
-$95,238
Shares: -16,422
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 59,000
Shares: 75,422
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 59,000 | 0 | $105,439 | $0 | +$105,439 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 75,422 | $0 | $200,677 | -$200,677 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 27 reporting-owner rows connected to Health Catalyst, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
27
Largest Forms 3/4/5 holder
Mathew Paul Arens
Net 12M change
-$95,238
Latest report
14 Sep 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Mathew Paul Arens | Director, 10%+ Owner | $32,429,283 | Mixed | 01 Dec 2025 | ||
| Simeon Kohl | Chief Executive Officer, Director | $5,104,645 | +$105,439 | +2.1% | Filing P/S | 14 Sep 2026 |
| Daniel D. Burton | Chief Executive Officer, Director | $4,040,265 | Mixed | 01 Dec 2025 | ||
| James Patrick Nelli Jr. | President | $2,869,452 | Mixed | 01 Sep 2022 | ||
| Benjamin Albert | CEO, Director | $2,762,927 | Median | 10 Sep 2026 | ||
| Paul Horstmeier | Chief Operating Officer | $2,218,256 | Mixed | 22 Mar 2023 | ||
| Bryan Truman Hunt | Chief Financial Officer | $1,770,048 | Mixed | 01 Mar 2024 | ||
| Daniel H. Orenstein | General Counsel | $1,441,055 | Mixed | 01 Mar 2023 | ||
| Jason Alger | Chief Financial Officer | $1,402,685 | Median | 01 Sep 2026 | ||
| Kevin Lee Freeman | Chief Commercial Officer | $1,040,261 | Mixed | 01 Dec 2025 | ||
| Benjamin Landry | General Counsel | $699,230 | -$72,328 | -9.4% | Median | 01 Sep 2026 |
| Anne Marie Bickmore | COO and Chief Product Officer | $689,903 | Mixed | 01 Dec 2023 | ||
| David Coy Ross | Chief Tech & Product Officer | $686,727 | Mixed | 02 Sep 2025 | ||
| Daniel LeSueur | Chief Operating Officer | $667,048 | Mixed | 02 Sep 2025 | ||
| KANE JOHN A | Director | $643,610 | Mixed | 09 Jul 2025 | ||
| Anita Pramoda | Director | $494,318 | Mixed | 01 Dec 2024 | ||
| D. Fraser Bullock | Director | $487,209 | Mixed | 10 Jun 2021 | ||
| Steven H. Nelson | Director | $468,643 | Median | 16 Jul 2026 | ||
| Mark B. Templeton | Director | $426,155 | Mixed | 14 Jun 2023 | ||
| Linda Llewelyn | Chief People Officer | $407,837 | Mixed | 01 Jun 2026 |
Recent insider transactions for Health Catalyst, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Simeon Kohl | HCAT | Common Stock | Purchase | 2.11% | $105,439 | $1.79 | 59,000 | 2,856,385 | 14 Sep 2026 | Direct |
| Simeon Kohl | HCAT | Common Stock | Award | 5494.8% | 2,747,385 | 2,797,385 | 14 Sep 2026 | Direct | ||
| Benjamin Albert | HCAT | Common Stock | Tax liability | -2.48% | -35,244 | 1,388,406 | 10 Sep 2026 | Direct | ||
| Julie Larson-Green | HCAT | Common Stock | Award | 5.57% | 9,766 | 185,101 | 01 Sep 2026 | Direct | ||
| Jason Alger | HCAT | Common Stock | Tax liability | -2.49% | -17,973 | 704,867 | 01 Sep 2026 | Direct | ||
| Benjamin Albert | HCAT | Common Stock | Tax liability | -0.02% | -321 | 1,423,650 | 01 Sep 2026 | Direct | ||
| Benjamin Landry | HCAT | Common Stock | Tax liability | -3.61% | -13,167 | 351,372 | 01 Sep 2026 | Direct | ||
| Green Jill Hoggard | HCAT | Common Stock | Award | 126.2% | 80,691 | 144,628 | 16 Jul 2026 | Direct | ||
| Julie Larson-Green | HCAT | Common Stock | Award | 85.3% | 80,691 | 175,335 | 16 Jul 2026 | Direct | ||
| Steven H. Nelson | HCAT | Common Stock | Award | 52.1% | 80,691 | 235,499 | 16 Jul 2026 | Direct | ||
| Justin Spencer | HCAT | Common Stock | Award | 117.7% | 80,691 | 149,263 | 16 Jul 2026 | Direct | ||
| Benjamin Albert | HCAT | Common Stock | Tax liability | -2.36% | -34,485 | 1,423,971 | 10 Jun 2026 | Direct | ||
| Benjamin Albert | HCAT | Common Stock | Tax liability | -0.02% | -336 | 1,458,456 | 01 Jun 2026 | Direct | ||
| Linda Llewelyn | HCAT | Common Stock | Tax liability | -2.58% | -8,519 | 321,132 | 01 Jun 2026 | Direct | ||
| Jason Alger | HCAT | Common Stock | Tax liability | -2.54% | -18,804 | 722,840 | 01 Jun 2026 | Direct | ||
| Benjamin Landry | HCAT | Common Stock | Tax liability | -3.64% | -13,779 | 364,539 | 01 Jun 2026 | Direct | ||
| Julie Larson-Green | HCAT | Common Stock | Award | 15.5% | 12,710 | 94,644 | 01 Jun 2026 | Direct | ||
| Steven H. Nelson | HCAT | Common Stock | Award | 154,808 | 154,808 | 01 May 2026 | Direct | |||
| Benjamin Albert | HCAT | Common Stock | Tax liability | -0.02% | -310 | 1,458,792 | 01 May 2026 | Direct | ||
| Benjamin Albert | HCAT | Common Stock | Award | 0.08% | 1,124 | 1,459,102 | 29 Apr 2026 | Direct | ||
| Benjamin Albert | HCAT | Common Stock | Tax liability | -4.61% | -70,455 | 1,457,978 | 10 Mar 2026 | Direct | ||
| Benjamin Landry | HCAT | Common Stock | Tax liability | -5.22% | -20,838 | 378,318 | 02 Mar 2026 | Direct | ||
| Jason Alger | HCAT | Common Stock | Tax liability | -3.51% | -26,970 | 741,644 | 02 Mar 2026 | Direct | ||
| Benjamin Albert | HCAT | Common Stock | Tax liability | -0.32% | -4,966 | 1,528,433 | 02 Mar 2026 | Direct | ||
| Linda Llewelyn | HCAT | Common Stock | Tax liability | -4.03% | -13,836 | 329,651 | 02 Mar 2026 | Direct | ||
| Julie Larson-Green | HCAT | Common Stock | Award | 11.4% | 8,361 | 81,934 | 01 Mar 2026 | Direct | ||
| Benjamin Albert | HCAT | Common Stock | Tax liability | -0.86% | -13,304 | 1,533,399 | 26 Feb 2026 | Direct | ||
| Linda Llewelyn | HCAT | Common Stock | Tax liability | -1.28% | -4,471 | 343,487 | 26 Feb 2026 | Direct | ||
| Benjamin Landry | HCAT | Common Stock | Tax liability | -1.56% | -6,317 | 399,156 | 26 Feb 2026 | Direct | ||
| Jason Alger | HCAT | Common Stock | Tax liability | -0.97% | -7,522 | 768,614 | 26 Feb 2026 | Direct | ||
| Benjamin Albert | HCAT | Common Stock | Award | 167.7% | 968,833 | 1,546,703 | 25 Feb 2026 | Direct | ||
| Linda Llewelyn | HCAT | Common Stock | Award | 142.9% | 204,695 | 347,958 | 25 Feb 2026 | Direct | ||
| Benjamin Landry | HCAT | Common Stock | Award | 305.5% | 305,473 | 405,473 | 25 Feb 2026 | Direct | ||
| Jason Alger | HCAT | Common Stock | Award | 215% | 529,722 | 776,136 | 25 Feb 2026 | Direct | ||
| Duncan Gallagher | HCAT | Common Stock | Award | 6.08% | 7,562 | 132,023 | 17 Feb 2026 | Direct | ||
| Benjamin Landry | HCAT | Common Stock | Sale | -21.5% | $72,328 | $2.64 | -27,425 | 100,000 | 05 Dec 2025 | Direct |
| Julie Larson-Green | HCAT | Common Stock | Sale | -39.5% | $128,349 | $2.67 | -47,997 | 73,573 | 04 Dec 2025 | Direct |
| Julie Larson-Green | HCAT | Common Stock | Award | 4.95% | 5,731 | 121,570 | 01 Dec 2025 | Direct | ||
| Duncan Gallagher | HCAT | Common Stock | Award | 5.25% | 6,209 | 124,461 | 01 Dec 2025 | Direct | ||
| Benjamin Landry | HCAT | Common Stock | Tax liability | -10.2% | -14,387 | 127,425 | 01 Dec 2025 | Direct | ||
| Linda Llewelyn | HCAT | Common Stock | Tax liability | -6.38% | -9,762 | 143,263 | 01 Dec 2025 | Direct | ||
| Kevin Lee Freeman | HCAT | Common Stock | Tax liability | -4.37% | -16,401 | 358,686 | 01 Dec 2025 | Direct | ||
| Jason Alger | HCAT | Common Stock | Tax liability | -7.72% | -20,619 | 246,414 | 01 Dec 2025 | Direct | ||
| Daniel D. Burton | HCAT | Common Stock | Tax liability | -3.85% | -55,715 | 1,393,099 | 01 Dec 2025 | Direct |
* marks a reported price that did not pass the local price check.